Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Nikes quarterly results and weak full-year outlook are dominating discussion: traders cite falling revenue, continued China weakness, and expectations for further declines as reasons for the selloff. Others point to an earnings beat, improved margins, North American growth, and the dividend as reasons to see value, though many remain doubtful the turnaround is working.

AppLovins sharp selloff is being tied largely to Wells Fargos doubts about the quality of the companys e-commerce pixel-install growth, alongside broader concerns about growth durability, competition from Unity, and litigation. Bulls call the decline an overreaction and point to the profitable core ad business, while bears worry that e-commerce expansion may not deliver as hoped.

Netflixs sharp selloff has traders focused on concerns about slowing growth and weaker U.S. engagement, reinforced by managements acknowledgment that growth is not fast enough and uncertainty ahead of the next earnings report. Bears fear competition and continued declines, while bulls point to international growth, advertising potential, the recent Deutsche Bank upgrade, and a lower valuation as reasons for optimism.

Cortevas sharp share-price reset follows the completed spin-off of its seed business into Vylor, with shareholders receiving shares in the new company; the headline drop is largely mechanical rather than a standalone business collapse. Traders are debating whether post-spin selling has left Cortevas remaining crop-protection business undervalued or whether its new valuation could fall further.

Nektars rezpegaldesleukin update in alopecia and atopic dermatitis is driving attention, with traders focused on continued hair-regrowth responses and maintained eczema benefits. The sharp selloff despite the update has split the community: bulls emphasize potential durability, while others view the results as modest and based on small patient groups; claims of a short attack remain speculation.

PUMP.funs token is drawing attention amid renewed rebound and breakout talk, with traders citing the platforms revenue and buybacks, along with activity in Solana memecoins, as bullish factors. Others warn of volatility and selloffs, and debate whether the momentum can last.

Realty Income is drawing attention after an extended slide to fresh 52-week lows, with traders largely blaming rising Treasury yields and expectations for higher-for-longer interest rates that pressure REIT valuations and make bonds more competitive. The community is split between buying the dip for the increasingly attractive monthly dividend yield and waiting for further declines; some also worry about share issuance and dilution.

Evernorths approved business combination with Armada and planned Nasdaq listing as an XRP treasury company are driving attention, with traders focused on its expected XRP holdings and the possibility that SPAC redemptions leave a limited public float. Bulls are treating the move as leveraged exposure to XRP, while skeptics warn that SPAC dynamics, dilution, and XRPs volatility could undercut the rally.

Disneys roughly 3% decline has traders debating the cause: some point to reports of television-business restructuring and job cuts, while others say the move lacks a clear catalyst and focus on technical weakness and support levels. Several traders note the drop came on below-average volume, leaving debate over whether it signals further selling or a temporary breakdown.

Nuvation Bio is drawing attention for safusidenibs FDA Fast Track designation and encouraging glioma data, alongside IBTROZIs commercial progress and updated label. Many traders see the milestones as strengthening the pipeline and commercial case, while others focus on weak share performance, competition and short-interest concerns; buyout talk remains speculative.